Walgreens Boots Alliance
About: Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Employees: 312,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
0% more funds holding in top 10
Funds holding in top 10: 4 [Q2] → 4 (+0) [Q3]
2.6% less ownership
Funds ownership: 62.05% [Q2] → 59.45% (-2.6%) [Q3]
6% less funds holding
Funds holding: 917 [Q2] → 862 (-55) [Q3]
11% less call options, than puts
Call options by funds: $246M | Put options by funds: $274M
18% less repeat investments, than reductions
Existing positions increased: 276 | Existing positions reduced: 338
25% less first-time investments, than exits
New positions opened: 114 | Existing positions closed: 153
29% less capital invested
Capital invested by funds: $6.48B [Q2] → $4.62B (-$1.86B) [Q3]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Truist Securities David Macdonald 57% 1-year accuracy 55 / 96 met price target | 14%upside $13 | Hold Maintained | 16 Jan 2025 |
RBC Capital Ben Hendrix 30% 1-year accuracy 21 / 70 met price target | 6%upside $12 | Sector Perform Maintained | 15 Jan 2025 |
Evercore ISI Group Elizabeth Anderson 39% 1-year accuracy 13 / 33 met price target | 6%upside $12 | In-Line Maintained | 13 Jan 2025 |
B of A Securities Allen Lutz 69% 1-year accuracy 9 / 13 met price target | 25%downside $8.50 | Underperform Maintained | 13 Jan 2025 |
Jefferies Brian Tanquilut 50% 1-year accuracy 7 / 14 met price target | 21%downside $9 | Hold Maintained | 23 Oct 2024 |
Financial journalist opinion
Based on 85 articles about WBA published over the past 30 days